Skip to content

Clinical trials

Completed Coronary Disease trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Status: Completed Country / region: Taiwan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20101
20111
20121
20191
20201
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Abbott Medical Devices1
Amgen1
AstraZeneca1
Chang Gung University of Science and Technology1
Kaohsiung Veterans General Hospital.1
NYU Langone Health1
Sanofi1
Taipei Medical University WanFang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease10
Cardiovascular Diseases4
Coronary Artery Disease3
Heart Diseases3
Acute Coronary Syndrome2
Atherosclerosis2
Myocardial Ischemia2
Coronary Restenosis1
Coronary Stenosis1
Multiple Endocrine Neoplasia Type 11

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.